Abstract
Taking a One Health approach to infectious diseases common to both dogs and people, pet insurance claims from 2008-2022 in the United States were compared to publicly available CDC-based data on human cases for Lyme disease, giardia, and Valley Fever (coccidioidomycosis). Despite having very different causative agents and etiologies, the disease trends for these three diseases were very similar between people and dogs both geographically and temporally. We furthermore demonstrated that adding dog data to the human data improves prediction models for those same diseases. With machine learning prediction tools for the pet insurance to increase prediction times and alert public health officials, pet insurance data could be a helpful tool to predict and detect diseases by estimating even earlier the effects of these common exposure diseases on human health. We also show the spatiotemporal distribution of intestinal worm diagnoses in dogs, and while it could not be directly compared to human data because the corresponding disease in humans (soil-transmitted helminths) has not been well monitored recently. However, these data can help inform researchers and public health workers.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was funded by Fetch Pet Insurance.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
Data is provided within the manuscript and all datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.